Search Results 21-30 of 16935 for citrulline loading phase
Patients in the study will be treated with Melphalan/HDS and will receive up to 6 total treatments. This study will evaluate the safety and effects of the ...
There are also less common very early (phase 0) and later (phase 4) phases. ... load must be undetectable on suppressive therapy, if indicated, to be eligible.
Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines ...
Part 2 (monotherapy dose expansion) will further evaluate the safety, efficacy, pharmacokinetics (PK), and pharmacodynamics (PD) of the recommended Phase 2 dose ...
Study PT-112-102, a multicenter, open-label dose-finding and pharmacokinetic study of PT-112 in patients with relapsed or refractory multiple myeloma. This is ...
This is a phase 2, multicenter, open-label study in patients with Newly Diagnosed Multiple Myeloma (NDMM) who have not received prior systemic treatment for ...
About this study. This phase II trial studies how well cabozantinib-s-malate works in treating patients with thyroid cancer that does not respond to ...
Symptoms of end-stage liver disease may include: Easy bleeding or bruising; Persistent or recurring yellowing of your skin and eyes (jaundice); Intense itching ...
About this study. This is a multicenter, open-label, Phase 1 study in participants with colorectal cancer (CRC), and consists of Part A (dose regimen ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.